NOW Program Educational Webinars: IDH-Mutant Gliomas

preview_player
Показать описание
An interactive, educational webinar on IDH-mutant gliomas and their treatment, led by Dana-Farber neuro-oncologists.

  1. Dana-Farber Cancer Institute
  2. Dana-Farber Cancer Institute
  3. DFCI
  4. Dana-Farber
  5. cancer
Рекомендации по теме
NOW Program Educational 1:00:07

NOW Program Educational Webinars: IDH-Mutant Gliomas

NOW Educational Programming: 0:53:14

NOW Educational Programming: IDH-mutant Gliomas

NOW Program Educational 0:45:21

NOW Program Educational Webinar Series: Brain Tumor Symptoms

Vorasidenib in IDH-Mutant 0:02:23

Vorasidenib in IDH-Mutant Glioma | NEJM

CDKN2B DELETION IN 0:00:28

CDKN2B DELETION IN IDH MUTANT GLIOMA

How Do IDH 0:01:02

How Do IDH Mutations Cause Tumors?

IDH Mutations in 0:01:36

IDH Mutations in Cancer

EANS WEBINAR: GLIOMAS 2:11:46

EANS WEBINAR: GLIOMAS

Addressing treatment options 0:01:21

Addressing treatment options for IDH-mutant gliomas

New Treatment for 0:18:21

New Treatment for IDH mt Gliomas

Genomics and Cancer 1:05:03

Genomics and Cancer Biomarkers for HCC: Potential Applications

How the Neurosurgeon 0:30:37

How the Neurosurgeon Uniquely Meets the Unmet Need in Today's Precision Medicine Era

Developments in Treating 1:00:41

Developments in Treating Malignant Brain Tumors

IDH1 mutation, histology, 0:05:16

IDH1 mutation, histology, and treatment of tissue metabolites in diffuse glioma

WEBINAR: Update on 0:55:46

WEBINAR: Update on the International Low Grade Glioma Registry 1

Pediatric High-Grade Gliomas: 0:00:06

Pediatric High-Grade Gliomas: Genetic Subtypes of Histone H3G34, H3K27, and IDH-1 Mutant Tumors

Research Discussion: AI 1:01:31

Research Discussion: AI in Radiology with Dr. Filippi

Neuro-Oncology Webinar Series 1:10:45

Neuro-Oncology Webinar Series (NOWS) Dr. Ahmed Gilani

ABTA: Molecular Testing: 0:47:57

ABTA: Molecular Testing: How it is Used to Guide Treatment Decisions

AML Non-Transplant Options: 1:17:29

AML Non-Transplant Options: What's in the Pipeline? (2018)

Neuroncology Panel Discussion 0:42:06

Neuroncology Panel Discussion

Innovations In Hematology 1:02:54

Innovations In Hematology

Interactive Case Review: 0:08:19

Interactive Case Review: T2 Non-Enhancing Lesion

Effective Program of 1:11:42

Effective Program of ACOD Webinar 30 1 2020

visit shbcf.ru